Search results for "Highlights"
Sodium polystyrene sulfonate associated with GI events requiring hospitalization in elderly
An accompanying editorial said that based on the risk of gastrointestinal (GI) events found in this retrospective study, sodium polystyrene sulfonate should not be used to reduce serum potassium levels.
https://gastroenterology.acponline.org/archives/2019/06/28/2.htm
28 Jun 2019
Two-year results show continued benefit of phone or web CBT for refractory IBS
Patients with irritable bowel syndrome (IBS) who had been randomized to receive remote cognitive behavioral therapy (CBT) had lower symptom severity scores than those who had received usual care, according to follow-up data from a British trial.
https://gastroenterology.acponline.org/archives/2019/09/27/3.htm
27 Sep 2019
Efficacy, safety of second-line therapies analyzed for two types of IBS
A systematic review and network meta-analysis focused on alosetron, eluxadoline, ramosetron, and rifaximin in adult patients who had irritable bowel syndrome (IBS) with diarrhea or mixed stool.
https://gastroenterology.acponline.org/archives/2019/04/26/2.htm
26 Apr 2019
Weight loss interventions may improve biomarkers of liver disease in NAFLD
In a meta-analysis of 22 studies in patients with nonalcoholic fatty liver disease (NAFLD), weight loss interventions were associated with improvements in alanine aminotransferase level, liver steatosis, histologic NAFLD activity score, and nonalcoholic steatohepatitis.
https://gastroenterology.acponline.org/archives/2019/07/26/3.htm
26 Jul 2019
Hepatitis A infections nearly triple, with some states seeing 5-fold increase, CDC says
The increase primarily occurred among people who reported drug use or homelessness.
https://gastroenterology.acponline.org/archives/2019/05/24/2.htm
24 May 2019
Semaglutide showed some benefit in patients with NASH, liver fibrosis
Significantly more patients taking the glucagon-like peptide-1 receptor agonist had resolution of their nonalcoholic steatohepatitis (NASH) than those taking placebo, but rates of liver fibrosis improvement were similar between groups, an industry-funded trial found.
https://gastroenterology.acponline.org/archives/2020/11/20/1.htm
20 Nov 2020
Spotlight on esophageal adenocarcinoma
High-dose proton-pump inhibitors and aspirin appeared effective for chemoprevention in patients with Barrett's esophagus in one study, while another study found a positive association between human papillomavirus status and survival in patients with Barrett's high-grade dysplasia and esophageal adenocarcinoma.
https://gastroenterology.acponline.org/archives/2018/08/24/5.htm
24 Aug 2018
Treatment algorithm updated for chronic HBV
The recommendations address use of newer therapies and are intended to offer guidance on treating chronic hepatitis B virus (HBV) infection while additional antiviral agents are in development.
https://gastroenterology.acponline.org/archives/2021/08/27/1.htm
27 Aug 2021
Drinking coffee may reduce risk of death, disease progression in patients with advanced colorectal cancer, study finds
An editorial noted coffee's unique role in diet, as it is widely consumed as a daily habit, and explained why a potential link between coffee consumption and colorectal cancer is biologically plausible.
https://gastroenterology.acponline.org/archives/2020/09/25/1.htm
25 Sep 2020
Study finds higher proportion of CRC diagnoses in patients under 50 since 2004
Based on the results, study authors suggested expanding colorectal cancer (CRC) screening to patients 45 years of age, but an accompanying editorial expressed concern that the risks could outweigh the benefits in the general population.
https://gastroenterology.acponline.org/archives/2019/07/26/2.htm
26 Jul 2019